Small Molecules, ADCs, Bispecifics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
263
NCT06234423
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 9, 2024
Completion: Oct 31, 2027
Loading map...